TOKYO -- Japanese drugmaker Eisai will boost new graduate hires by 40% in the fiscal year starting in April as it plans to expand its sales force for its breakthrough Alzheimer's treatment, Nikkei has learned.
Pharmaceuticals
Japan's Eisai to boost sales staff to focus on new Alzheimer's drug
Drugmaker to hire 40% more new grads following lecanemab approval in Japan, U.S.
With its hiring binge, Eisai is trying to steal a march on Eli Lilly, which might have a similar treatment approved in the U.S. by the end of the year. (Photo by Nanami Sato)
Read Next
Latest on Pharmaceuticals
